These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Acute liver injury associated with glucosamine dietary supplement. Ebrahim V; Albeldawi M; Chiang DJ BMJ Case Rep; 2012 Dec; 2012():. PubMed ID: 23239775 [TBL] [Abstract][Full Text] [Related]
3. Colestipol granules in the colon: macroscopic and microscopic findings. Gonzalez RS; Schwartz DA; Shi C Histopathology; 2015 Jul; 67(1):141-2. PubMed ID: 25406854 [No Abstract] [Full Text] [Related]
4. Low dose colestipol in adolescents with familial hypercholesterolaemia. Tonstad S; Sivertsen M; Aksnes L; Ose L Arch Dis Child; 1996 Feb; 74(2):157-60. PubMed ID: 8660081 [TBL] [Abstract][Full Text] [Related]
5. Defining patient risks from expanded preventive therapies. Tolman KG Am J Cardiol; 2000 Jun; 85(12A):15E-9E. PubMed ID: 10858489 [TBL] [Abstract][Full Text] [Related]
6. A randomized crossover trial of combination pharmacologic therapy in children with familial hyperlipidemia. McCrindle BW; Helden E; Cullen-Dean G; Conner WT Pediatr Res; 2002 Jun; 51(6):715-21. PubMed ID: 12032266 [TBL] [Abstract][Full Text] [Related]
8. [Long term treatment of familial hypercholesterolemia with Colestipol, a new anionic exchange resin (author's transl)]. Briani G; Fellin R; Balestrieri P; Baggio G; Baiocchi MR; Crepaldi G G Ital Cardiol; 1975; 5(3):390-404. PubMed ID: 1149965 [TBL] [Abstract][Full Text] [Related]
9. Fenofibrate and colestipol: effects on serum and lipoprotein lipids and apolipoproteins in familial hypercholesterolaemia. Weisweiler P; Merk W; Jacob B; Schwandt P Eur J Clin Pharmacol; 1986; 30(2):191-4. PubMed ID: 3709644 [TBL] [Abstract][Full Text] [Related]
10. Characterisation of Agomelatine-Induced Increase in Liver Enzymes: Frequency and Risk Factors Determined from a Pooled Analysis of 7605 Treated Patients. Perlemuter G; Cacoub P; Valla D; Guyader D; Saba B; Batailler C; Moore K CNS Drugs; 2016 Sep; 30(9):877-88. PubMed ID: 27342740 [TBL] [Abstract][Full Text] [Related]
11. [Pulmonary tuberculosis with chemotherapy related liver dysfunction]. Yasuda K; Sato A; Chida K; Shichi I; Kishimoto H; Wada R; Tatsuta Y; Honda A; Yamazaki A Kekkaku; 1990 Jun; 65(6):407-13. PubMed ID: 2388450 [TBL] [Abstract][Full Text] [Related]
12. Colestipol: a review of its pharmacological properties and therapeutic efficacy in patients with hypercholesterolaemia. Heel RC; Brogden RN; Pakes GE; Speight TM; Avery GS Drugs; 1980 Mar; 19(3):161-80. PubMed ID: 6988203 [TBL] [Abstract][Full Text] [Related]
13. Elevated Transaminases with Topical Diclofenac: A Case Report. Daniels AM; Gibbs LM; Herndon CM J Pain Palliat Care Pharmacother; 2018; 32(2-3):161-164. PubMed ID: 30645151 [TBL] [Abstract][Full Text] [Related]
14. Long-term effects of colestipol (U-26,597 A) on plasma lipids in familial type II hyperbetalipoproteinaemia. Fellin R; Briani G; Balestrieri P; Baggio G; Baiocchi MR; Crepaldi G Atherosclerosis; 1975; 22(3):431-45. PubMed ID: 1201145 [TBL] [Abstract][Full Text] [Related]
15. Pemoline hepatotoxicity in children. Marotta PJ; Roberts EA J Pediatr; 1998 May; 132(5):894-7. PubMed ID: 9602211 [TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor alpha-mediated drug toxicity in the liver. Hedrington MS; Davis SN Expert Opin Drug Metab Toxicol; 2018 Jul; 14(7):671-677. PubMed ID: 29847748 [TBL] [Abstract][Full Text] [Related]
17. Combination therapy with colestipol and psyllium mucilloid in patients with hyperlipidemia. Spence JD; Huff MW; Heidenheim P; Viswanatha A; Munoz C; Lindsay R; Wolfe B; Mills D Ann Intern Med; 1995 Oct; 123(7):493-9. PubMed ID: 7661492 [TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy of colestipol and clofibrate in type IIa hyperlipoproteinemia. Vecchio TJ; Linden CV; O'Connell MJ; Heilman J Arch Intern Med; 1982 Apr; 142(4):721-3. PubMed ID: 7073415 [TBL] [Abstract][Full Text] [Related]